Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity

Published:2015 Issue: Volume:2 Page:15012
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Ayala Breton Camilo,Wikan Nitwara,Abbuhl Arinda,Smith Duncan R,Russell Stephen J,Peng Kah-Whye

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference32 articles.

1. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications;Iqbal;Mol Biol Int,2014

2. HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies;English;Mol Diagn Ther,2013

3. The role of HER2 in cancer therapy and targeted drug delivery;Tai;J Control Release,2010

4. Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab;Gradishar;Ann Oncol,2013

5. Viruses for tumor therapy;Bell;Cell Host Microbe,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Therapy of Solid Tumors by Modified Vesicular Stomatitis Virus;DNA and Cell Biology;2023-12-11

2. A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon;Molecular Therapy - Oncolytics;2023-09

3. Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors;Journal of Virology;2023-06-29

4. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation;Viral Vectors in Cancer Immunotherapy;2023

5. Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers;Molecular Therapy - Oncolytics;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3